Literature DB >> 15941701

High and rising health care costs. Part 2: technologic innovation.

Thomas Bodenheimer1.   

Abstract

Technologic innovation, in combination with weak cost-containment measures, is a major factor in high and rising health care costs. Evidence suggests that improved health care technologies generally increase rather than reduce health care expenditures. Greater availability of such technologies as magnetic resonance imaging, computed tomography, coronary artery bypass graft, angioplasty, cardiac and neonatal intensive care units, positron emission tomography, and radiation oncology facilities is associated with greater per capita use and higher spending on these services. Because the spread of new technologies is relatively unrestrained in the United States, many of these technologies are used to a greater extent than in other nations, and the United States thereby incurs higher health care costs. Nations with a greater degree of health system integration have relied on expenditure controls and global budgets to control costs. Although diffusion of technology takes place more slowly in more tightly budgeted systems, the use of innovative technologies in those systems tends to catch up over time.

Mesh:

Year:  2005        PMID: 15941701     DOI: 10.7326/0003-4819-142-11-200506070-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  44 in total

1.  Variations in the use of an innovative technology by payer: the case of drug-eluting stents.

Authors:  Andrew J Epstein; Jonathan D Ketcham; Saif S Rathore; Peter W Groeneveld
Journal:  Med Care       Date:  2012-01       Impact factor: 2.983

2.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

3.  Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.

Authors:  Klaus Bonaventura; Alexander W Leber; Christian Sohns; Mattias Roser; Leif-Hendrik Boldt; Franz X Kleber; Wilhelm Haverkamp; Marc Dorenkamp
Journal:  Clin Res Cardiol       Date:  2012-02-21       Impact factor: 5.460

4.  A multicenter, prospective, advanced diagnostic bronchoscopy outcomes registry.

Authors:  Armin Ernst; Michael Simoff; David Ost; Gaetane Michaud; Divay Chandra; Felix J F Herth
Journal:  Chest       Date:  2010-04-02       Impact factor: 9.410

5.  New technology and the cost of health care.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

Review 6.  Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process.

Authors:  Ron Goeree; Leslie Levin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Resource allocation among cardiovascular specialists and trainees: a pilot survey.

Authors:  James M Brophy
Journal:  Can J Cardiol       Date:  2008-02       Impact factor: 5.223

Review 8.  The redefinition of aging in American surgery.

Authors:  Mark D Neuman; Charles L Bosk
Journal:  Milbank Q       Date:  2013-06       Impact factor: 4.911

9.  Why U.S. health care expenditure and ranking on health care indicators are so different from Canada's.

Authors:  A H G M Spithoven
Journal:  Int J Health Care Finance Econ       Date:  2008-07-01

10.  The timing of adoption of positron emission tomography: a real options approach.

Authors:  Paolo Pertile; Emanuele Torri; Luciano Flor; Stefano Tardivo
Journal:  Health Care Manag Sci       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.